Skip to search formSkip to main contentSkip to account menu

YKP10811

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Prokinetic effects of a new 5‐HT4 agonist, YKP10811, on gastric motility in dogs
Prokinetics have been considered the first‐line medicine for treating delayed gastric emptying. The aim of this study was to… 
2015
2015
Funktionelle Obstipation – Effektivität und Sicherheit von YKP10811
2014
2014
236 All Oral Fixed-Dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Experienced Genotype 1 HCVInfected Patients: The Phase 3 Ion-2 Study
2014
2014
Tu2039 TURQUOISE-II: SVR12 Rates of 92%-96% in 380 Hepatitis C Virus Genotype 1-Infected Adults with Compensated Cirrhosis Treated with ABT-450/r/ABT-267 and ABT-333 plus Ribavirin (3D+RBV)
2014
2014
Tu2037 Effects of YKP10811, a Selective 5-HT4 Receptor Agonist, in Patients with Functional Constipation: A Randomized, Controlled, Phase II Study
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)